Publisher
Springer International Publishing
Reference44 articles.
1. Koolen BB, Vrancken Peeters MJTFD, Aukema TS, et al. 18F-FDG PET/CT as staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat. 2012;131:117–26.
2. Groheux D, Giacchetti S, Espie M, et al. Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim. Eur J Nucl Med Mol Imaging. 2011;38:419–25.
3. Koolen BB, Vogel WV, Vrancken Peeters MJTFD, et al. Molecular imaging of breast cancer: from whole-body PET/CT to dedicated breast PET. J Oncol. 2012;2012:438647.
4. Pace L, Nicolai E, Luongo A, et al. Comparison of whole body PET/CT and PET/MRI in breast cancer patients: lesion detection and quatitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol. 2014;83:289–96.
5. Hoefnagel CA, Sivro-Prndelj F, Valdés Olmos RA. Lymphoscintigraphy and sentinel node procedures in breast carcinoma: role, techniques and safety aspects. World J Nucl Med. 2002;1:45–54.